Clinical Trial

Comparing a New 3D Technology Used to Measure Thyroid Nodule Volume to Standard Ultrasound

Enrolling by Invitation
View on ClinicalTrials.gov →
Summary
After thyroid ablation procedure, the volume of the thyroid nodule (s) needs to be measured to see how well the procedure worked. Currently, these volumes are measured using traditional 2D ultrasound imaging. However, this approach comes with limitations because of the information 2D images cannot gather and because of differences in these measurements between different doctors. A new ultrasound technology called PIUR 3D imaging offers a novel alternative approach. The system uses advanced technology to create 3D images and can generate automated volume estimates. The PIUR imaging system, PIUR tUS Infinity, has been cleared by the Food and Drug Administration (FDA) to aid in treatment decisions when used alongside traditional 2D ultrasound imaging. The purpose of this study is to test how effective and consistent the PIUR imaging technology is compared to standard 2D ultrasound in measuring thyroid nodule volume.
Trial Details
NCT Number NCT07178080
Lead Sponsor Sarasota Memorial Health Care System
Conditions Thyroid Nodules, Thyroid Nodule
Enrollment 75 participants
Start Date 2025-09-08
Primary Completion 2027-09-08 (estimated)
Study Completion 2027-09-08 (estimated)
Updated on ClinicalTrials.gov 2025-09-17